Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses”.
Blair V. Landon, Ali H. Zaidi, Dipika Singh, Jenna VanLiere Canzoniero, Archana Balan +26 more
Joyce J. Y. Lin, Rui Chen, Mina W. Tehrani, Andrew Schultze, Aryan Borole +4 more